Birth control and blood clots
FDA: Birth control drugs linked to 150 percent increased risk of deadly blood clots
2011 November 7
Instead of advising their patients to use natural and safe progesterone to treat menopause symptoms, many conventional doctors prescribe synthetic drospirenone instead. And a recent report issued by the US Food and Drug Administration (FDA) has found that women, who take birth control drugs containing this imitation progesterone drug, are 150 percent more likely to develop deadly blood clots than women not on the drugs.
Bayer’s Yasmin, Safyral, Yaz, Angeliq, and Beyaz birth control drugs all contain drospirenone, which is already known to cause cardiovascular problems, gastrointestinal disorders, nervous system dysfunction, vision problems, respiratory illness, and endocrine disruption. Now the FDA admits that the drug is linked to causing deadly blood clots known as venous thromboembolism as well.
For its analysis, the FDA evaluated study data on over 835,000 women ranging in age from ten to 55, all of whom had been taking drospirenone-containing birth control pills. Compared to women taking other or no birth control pills, the drospirenone women were found to have a 1.5 fold increased risk of developing deadly blood clots — and 4,246 of them developed venous thromboembolism for the first time during the study.